Screening outcomes
HCC, BCLC
A total of 298 patients across arms completed any imaging (US, MRI, or CT) in the 6-month period following the initial outreach. Of those, 14 (4.7%) had abnormal results or required additional follow-up evaluation. Based on medical record review to date, 11 (78.6%) were ordered follow-up imaging, 9 (81.8%) completed follow-up imaging, and 4 (44.4%) were diagnosed with HCC (Table Patients with any abnormal liver imaging (US, MRI, or CT) and subsequent careBarcelona Clinic Liver Cancer (BCLC) stage at diagnosis: 1 stage A, 2 stage B, and 1 stage C.Among the 298 patients who completed imaging, 34 (11.4%) had incidental findings that were not liver related (Table 